Mild Cognitive Impairment Clinical Trial
Official title:
Development and Evaluation of Support Groups for Patients With Mild Cognitive Impairment and Their Partners
This study aims at developing and evaluating a support group program for patients with mild
cognitive impairment (MCI) and their partners. These patients have defective memory function
but are not demented. However, there is an increased chance of developing dementia in the
near future; 10-15% per year for MCI patients, in contrast to 1-2% per year for healthy
elderly persons. For the patients and their caregivers this means that they are confronted
with feelings of uncertainty and fear towards the future. They also have many questions
about how to improve their memory problems and how to cope with other changes or
consequences.
The purpose of the support group program is to improve coping skills and facilitate
adaptation to the impairments, in order to reduce anxiety or depression and strengthen
feelings of competence in patients and their partners.
One of the consequences of the improved methodology for diagnosing dementia in a very early
stage is a growing group of patients in memory clinics who have cognitive deficits, which
exceed normal physiological aging processes but do not fulfil the criteria for dementia.
This category of patients with so-called 'Mild cognitive impairment' (MCI) is known to have
an increased risk at developing Dementia. For these patients, who have intact insight and
expressive skills, we expect that a psychosocial intervention may reduce feelings of
helplessness and anxiety and improve quality of life.
The group intervention was developed with respect to the 'stress adaptation coping model' of
Lazarus and the 'family support model' of Bengston and Kuypers.
Coming up with these models the aim is to teach participants to explore their attributions,
feelings and behaviour in order to enhance their coping strategies. This will increase the
feelings of competence and decrease feelings of helplessness.
In addition to these models we investigated the problems and themes as they are experienced
by MCI patients and their partners, using systematic interviews. This information resulted
in the following modules:
1. Understanding MCI and memory problems;
2. Exploring attributions and misconceptions;
3. Other changes;
4. Methods to improve memory performance;
5. Worrying and problem solving;
6. Losing activities and finding a new balance;
7. Tension and relaxation;
8. Managing conflicts;
9. Emotions.
These modules are worked through in 10 sessions, in 12 weeks. The group structure is as
follows: patients and parents meet separately the first 60 minutes, and then reconvene
together for the last half hour. This structure optimizes the sharing of each other's
experiences and prevents stigmatizing.
The main objective of the current study is to develop and evaluate a support group
intervention for patients with MCI and their partners. We expect that our support group
intervention will strengthen the partner's sense of competence to care for the patient and
will improve the quality of life of the patient and the partner as well.
;
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04513106 -
Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial
|
N/A | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
Active, not recruiting |
NCT03167840 -
Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment
|
N/A | |
Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
Not yet recruiting |
NCT05041790 -
A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment
|
Phase 4 | |
Recruiting |
NCT04121156 -
High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment
|
N/A | |
Recruiting |
NCT03605381 -
MORbidity PRevalence Estimate In StrokE
|
||
Completed |
NCT02774083 -
Cognitive Training Using Feuerstein Instrumental Enrichment
|
N/A | |
Completed |
NCT01315639 -
New Biomarker for Alzheimer's Disease Diagnostic
|
N/A | |
Enrolling by invitation |
NCT06023446 -
Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
|
||
Completed |
NCT04567745 -
Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers
|
Phase 1 | |
Recruiting |
NCT05579236 -
Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
|
||
Completed |
NCT03583879 -
Using Gait Robotics to Improve Symptoms of Parkinson's Disease
|
N/A | |
Terminated |
NCT02503501 -
Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease
|
Phase 2 | |
Not yet recruiting |
NCT03740178 -
Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005)
|
Phase 1 | |
Active, not recruiting |
NCT05204940 -
Longitudinal Observational Biomarker Study
|
||
Recruiting |
NCT02663531 -
Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease
|
N/A | |
Recruiting |
NCT06150352 -
Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
|
||
Recruiting |
NCT03507192 -
Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia.
|
N/A |